11-28023820-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_031217.4(KIF18A):c.2535C>T(p.Asp845Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00707 in 1,612,046 control chromosomes in the GnomAD database, including 47 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0052 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0073 ( 45 hom. )
Consequence
KIF18A
NM_031217.4 synonymous
NM_031217.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.604
Genes affected
KIF18A (HGNC:29441): (kinesin family member 18A) KIF18A is a member of the kinesin superfamily of microtubule-associated molecular motors (see MIM 148760) that use hydrolysis of ATP to produce force and movement along microtubules (Luboshits and Benayahu, 2005 [PubMed 15878648]).[supplied by OMIM, Aug 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 11-28023820-G-A is Benign according to our data. Variant chr11-28023820-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 769798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.604 with no splicing effect.
BS2
High AC in GnomAd4 at 790 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KIF18A | NM_031217.4 | c.2535C>T | p.Asp845Asp | synonymous_variant | 16/17 | ENST00000263181.7 | NP_112494.3 | |
KIF18A | XM_017018379.2 | c.2535C>T | p.Asp845Asp | synonymous_variant | 16/17 | XP_016873868.1 | ||
KIF18A | XM_017018380.2 | c.1203C>T | p.Asp401Asp | synonymous_variant | 8/9 | XP_016873869.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KIF18A | ENST00000263181.7 | c.2535C>T | p.Asp845Asp | synonymous_variant | 16/17 | 1 | NM_031217.4 | ENSP00000263181.6 |
Frequencies
GnomAD3 genomes AF: 0.00519 AC: 790AN: 152104Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
790
AN:
152104
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00562 AC: 1410AN: 250968Hom.: 8 AF XY: 0.00604 AC XY: 820AN XY: 135652
GnomAD3 exomes
AF:
AC:
1410
AN:
250968
Hom.:
AF XY:
AC XY:
820
AN XY:
135652
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00727 AC: 10614AN: 1459824Hom.: 45 Cov.: 30 AF XY: 0.00729 AC XY: 5294AN XY: 726258
GnomAD4 exome
AF:
AC:
10614
AN:
1459824
Hom.:
Cov.:
30
AF XY:
AC XY:
5294
AN XY:
726258
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00519 AC: 790AN: 152222Hom.: 2 Cov.: 32 AF XY: 0.00537 AC XY: 400AN XY: 74422
GnomAD4 genome
AF:
AC:
790
AN:
152222
Hom.:
Cov.:
32
AF XY:
AC XY:
400
AN XY:
74422
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
11
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 25, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2022 | KIF18A: BP4, BP7 - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at